Popular weight-loss drugs Ozempic and Wegovy may slow biological aging | HappeningNow.news

Science · 24 views

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging.

Source AI Summary Published July 14, 2026 Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 24 Community interest
Brief read Under 1 min brief 68 words

AI Summary

Research has identified a potential link between the active ingredient in certain weight-loss medications and biological aging. The study, which focused on adults with HIV, found that semaglutide slowed markers of biological aging. This is the first clinical evidence suggesting that the medication may influence human aging. While the findings are promising, scientists emphasize the need for further research before drawing conclusions about the medication's effects on aging.

AI summaries can be wrong sometimes—always verify important details using the source article.

How AI & Automation are used
Read original at Sciencedaily

More from Science

Continue reading recent Science coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page